Suppr超能文献

建立酮康唑抑制试验以在运动员兴奋剂检查中验证睾酮使用情况。

Establishing a ketoconazole suppression test for verifying testosterone administration in the doping control of athletes.

作者信息

Oftebro H, Jensen J, Mowinckel P, Norli H R

机构信息

Hormone Laboratory, Aker Hospital, Oslo, Norway.

出版信息

J Clin Endocrinol Metab. 1994 Apr;78(4):973-7. doi: 10.1210/jcem.78.4.8157729.

Abstract

The ratio of urinary testosterone (u-T) to epitestosterone (T/EpiT) is used to disclose testosterone (T) administration in the doping control of sports, and a ratio greater than 6 constitutes an offence. Nevertheless, the possibility of biological outliers must not be discounted, and the use of ketoconazole has been suggested for a dynamic test to distinguish between such athletes and those using T. In this investigation, ketoconazole was administrated to three groups of T-pretreated and two groups of untreated healthy male subjects. The subjects in one of the pretreated groups were patients with mild hypogonadism. One untreated group consisted of athletes that had been tested three times with high urinary T/EpiT levels. The effects of ketoconazole administration on serum T (s-T) level and urinary T/EpiT ratio were monitored every 2 h for an 8-h period and clearly separated T-pretreated and untreated subjects into two clusters (P < 0.0001). The T/EpiT ratio increased and the s-T level remained unchanged in pretreated individuals during the ketoconazole test, whereas T/EpiT decreased by 60% and s-T by almost 90% in untreated subjects. The statistical power of the test increased by using several time points and combining the urinary T/EpiT with the s-T data. In conclusion, the ketoconazole test is suitable as a supportive dynamic test for the urinary T/EpiT ratio measurements in the doping control of athletes.

摘要

尿睾酮(u-T)与表睾酮的比值(T/EpiT)用于在体育兴奋剂检测中揭示睾酮(T)的使用情况,比值大于6即构成违规。然而,不能忽视生物学异常值的可能性,有人建议使用酮康唑进行动态检测,以区分此类运动员和使用睾酮的运动员。在本研究中,对三组预先接受睾酮处理的健康男性受试者和两组未接受处理的健康男性受试者给予酮康唑。其中一组预先接受处理的受试者为轻度性腺功能减退患者。一组未接受处理的受试者为尿T/EpiT水平经三次检测均较高的运动员。在8小时内每2小时监测一次酮康唑给药对血清睾酮(s-T)水平和尿T/EpiT比值的影响,结果将预先接受睾酮处理的受试者和未接受处理的受试者明显分为两类(P < 0.0001)。在酮康唑检测期间,预先接受处理的个体的T/EpiT比值升高而s-T水平保持不变,而未接受处理的受试者的T/EpiT降低了60%,s-T降低了近90%。通过使用多个时间点并将尿T/EpiT与s-T数据相结合,检测的统计效能得以提高。总之,酮康唑检测适合作为运动员兴奋剂检测中尿T/EpiT比值测量的辅助动态检测方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验